Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
177.25
+0.80 (0.45%)
At close: Sep 25, 2026, 4:00 PM EDT
177.19
-0.06 (-0.03%)
After-hours: Sep 25, 2026, 7:59 PM EDT
Guardant Health Stock Forecast
Stock Price Forecast
According to 27 analysts polled by S&P Global, Guardant Health stock has a consensus rating of "Strong Buy" and an average price target of $196.38. The average 1-year stock price forecast is 10.79% higher than the current stock price, while the lowest is $105 (-40.76%) and the highest is $225 (+26.94%).
Price Target: $196.38 (+10.79%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 19 | 19 | 19 | 20 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 2 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 25 | 25 | 25 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Maintains $210 → $225 | Buy | Maintains | $210 → $225 | +26.94% | Sep 21, 2026 |
| Barclays | Barclays | Buy Maintains $200 | Buy | Maintains | $200 | +12.83% | Sep 18, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $193 | Buy | Maintains | $193 | +8.89% | Sep 15, 2026 |
| UBS | UBS | Buy Maintains $175 → $225 | Buy | Maintains | $175 → $225 | +26.94% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
1.36B
from 982.02M
Increased by 38.25%
Revenue Next Year
1.84B
from 1.36B
Increased by 35.51%
EPS This Year
-1.46
from -1.82
EPS Next Year
-0.40
from -1.46
EPS and Forward PE are based on non-GAAP adjusted numbers.